Mechanisms of Siglec-F-Induced Eosinophil Apoptosis: A Role for Caspases but Not for SHP-1, Src Kinases, NADPH Oxidase or Reactive Oxygen
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of Siglec-F-Induced Eosinophil Apoptosis: A Role for Caspases but Not for SHP-1, Src Kinases, NADPH Oxidase or Reactive Oxygen
Authors
Keywords
Eosinophils, Apoptosis, Mouse models, Protein kinases, Blood, Cell death, Kinase inhibitors, Mitochondria
Journal
PLoS One
Volume 8, Issue 6, Pages e68143
Publisher
Public Library of Science (PLoS)
Online
2013-06-29
DOI
10.1371/journal.pone.0068143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functionally Competent Eosinophils Differentiated Ex Vivo in High Purity from Normal Mouse Bone Marrow
- (2014) K. D. Dyer et al. JOURNAL OF IMMUNOLOGY
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils
- (2011) Ho Jeong Na et al. CYTOKINE
- Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression
- (2011) Sherry A. Hudson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Siglec-F Inhibition Reduces Esophageal Eosinophilia and Angiogenesis in a Mouse Model of Eosinophilic Esophagitis
- (2011) Eitan Rubinstein et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Characterization of Expression of Glycan Ligands for Siglec-F in Normal Mouse Lungs
- (2010) Jin P. Guo et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
- (2010) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis
- (2010) Sébastien Conus et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- What targeting eosinophils has taught us about their role in diseases
- (2010) Bruce S. Bochner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Basic and Clinical Immunology of Siglecs
- (2009) Stephan von Gunten et al. Annals of the New York Academy of Sciences
- Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model
- (2009) Dae Jin Song et al. CLINICAL IMMUNOLOGY
- Anti-Siglec-F Antibody Reduces Allergen-Induced Eosinophilic Inflammation and Airway Remodeling
- (2009) D. J. Song et al. JOURNAL OF IMMUNOLOGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils
- (2008) N. Zimmermann et al. ALLERGY
- A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils
- (2008) A. Munitz et al. BLOOD
- Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells
- (2008) Elizabeth A. Jacobsen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
- (2008) Marc E. Rothenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-5 Priming of Human Eosinophils Alters Siglec-8–Mediated Apoptosis Pathways
- (2007) Esra Nutku-Bilir et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by sialic acid–binding immunoglobulin-like lectin 8 engagement
- (2007) Hidenori Yokoi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now